Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05389540
Other study ID # HCR21013
Secondary ID
Status Completed
Phase
First received
Last updated
Start date October 3, 2022
Est. completion date December 10, 2023

Study information

Verified date February 2024
Source University of Oxford
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

A cross-sectional household survey with two-stage cluster-randomized sampling. This cross-sectional household survey design to recruit a random sample of households that is representative for each of the study sites. From the selected households, all consenting, household members will be included in the study. This study is funded by the UK Wellcome Trust. The grant reference number is 215604/Z/19/Z


Description:

371 households will be randomly selected from each site in Bangladesh, Cambodia, Myanmar, and Thailand. Assuming each household has an average of 4.5 members and all members will be sampled, 1500 participants will be recruited per site. This sample size allows for the overall prevalence estimation of key survey indicators with 95% confidence and 5% degree of precision. The survey components include questionnaire interview, physical examination, blood sample collection, and point of care (PoC) tests. The questionnaire interview will collect information on household characteristics, members' disability, presence or history of disease, risk factors, self-perceived quality of life, and health seeking behaviour. For women, questions about reproductive health and antenatal care, and for young children, vaccination coverage and achievement of child development goals, will also be assessed. For physical examinations, tympanic temperature, weight and height will be measured in all household members, mid-upper arm circumference in young children, and blood pressure in adults. Blood sample will be collected from all participants aged 6 months and above. Venous blood samples will be collected from participants aged 5 years and older, and dried blood spot will be collected from children under 5 years. Samples will be shipped to a central laboratory and analysed. Haemoglobin PoC will be administered to all participants. All data will be collected directly on an electronic case report form using tablets, and uploaded to an electronic database.


Recruitment information / eligibility

Status Completed
Enrollment 4747
Est. completion date December 10, 2023
Est. primary completion date December 10, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - All members of the selected households at the time of the survey; and able to provide informed consent. Exclusion Criteria: - Adults or children whose parent/guardian/ caretaker are unable or unwilling to provide informed consent.

Study Design


Locations

Country Name City State
Bangladesh BangladeshBuilding Resources Across Communities (BRAC) Dhaka
Cambodia Cambodia Action for Health Development (AHEAD) Battambang
Myanmar Medical Action Myanmar (MAM) Yangon
Thailand Chiangrai Clinical Research Unit (CCRU) Chiang Rai

Sponsors (6)

Lead Sponsor Collaborator
University of Oxford Bangladesh Rural Advancement Committee, Dhaka, Bangladesh, Cambodia Action for Health Development (AHEAD), Chiang Rai Clinical Research Unit, Thailand, Mahidol Oxford Tropical Medicine Research Unit, Myanmar Oxford Clinical Research Unit, Yangon, Myanmar

Countries where clinical trial is conducted

Bangladesh,  Cambodia,  Myanmar,  Thailand, 

References & Publications (1)

Chandna A, Chew R, Shwe Nwe Htun N, Peto TJ, Zhang M, Liverani M, Brummaier T, Phommasone K, Perrone C, Pyae Phyo A, Sattabongkot J, Roobsoong W, Nguitragool W, Sen A, Ibna Zaman S, Sandar Zaw A, Batty E, Waithira N, Abdad MY, Blacksell SD, Bodhidatta L, Callery JJ, Fagnark W, Huangsuranun W, Islam S, Lertcharoenchoke S, Lohavittayavikant S, Mukaka M, Moul V, Kumer Neogi A, Nedsuwan S, Pongvongsa T, Ponsap P, Richard-Greenblatt M, Schilling WHK, Thaipadungpanit J, Tripura R, Dondorp AM, Mayxay M, White NJ, Nosten F, Smithuis F, Ashley EA, Maude RJ, Day NPJ, Lubell Y. Defining the burden of febrile illness in rural South and Southeast Asia: an open letter to announce the launch of the Rural Febrile Illness project. Wellcome Open Res. 2022 Mar 10;6:64. doi: 10.12688/wellcomeopenres.16393.2. eCollection 2021. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Prevalence of long-lasting antibodies (IgG) against selected causes of non-malaria febrile illnesses Upon enrollment
Primary Prevalence of Plasmodium spp. by PCR Upon enrollment
Primary Prevalence of chronic Hepatitis B and C Upon enrollment
Primary Prevalence of selected non-communicable diseases (e.g. diabetes, chronic obstructive pulmonary diseases, stroke) according to self-reported disease history and laboratory tests Upon enrollment
Primary Prevalence of reported disability Upon enrollment
Primary Lifetime prevalence of reported injury or death caused by an accident Upon enrollment
Primary Self-rated overall health status Upon enrollment
Primary Questionnaire evaluation of health-related quality of life Upon enrollment
Primary Prevalence of self-reported tobacco, alcohol, and other substitute use among the population aged 15 and above Upon enrollment
Primary Prevalence of underweight and overweight, raised blood pressure and total cholesterol Upon enrollment
Secondary Evaluation of household wealth quartile according to self-reported household characteristics Upon enrollment
Secondary Education level, marital status, and occupation Upon enrollment
Secondary Self-reported health-related household characteristics (e.g. household cooking fuel, source of drinking water, possession of mosquito net) Upon enrollment
Secondary Proportion of population self-reported having sought for medical care in the past month, and care providers visited Upon enrollment
Secondary Self-reported antenatal care coverage among women who have ever given birth Upon enrollment
Secondary Reported vaccination coverage among children < 3 years Upon enrollment
Secondary Prevalence of reported exclusive breast feeding among children < 5 years Upon enrollment
Secondary Prevalence of children aged 3-4 years who have reached early child development milestones, reported by caretaker Upon enrollment
Secondary Presence of self-reported symptoms or diagnosed illness besides the outcome measures of the primary objectives Upon enrollment
Secondary Reported illness in the last month and type of illness Upon enrollment
Secondary Prevalence of IgM antibodies against selected acute non-malaria causes of febrile illness Upon enrollment
See also
  Status Clinical Trial Phase
Recruiting NCT06055777 - Study of the Safety, Tolerability, and PK of SZEY-2108 Administered Intravenously to HVs in SAD and MAD Cohorts Phase 1
Recruiting NCT05793983 - S100A8/A9 and Innate Immunity in Liver Disease
Active, not recruiting NCT05963269 - The Effect of the Game on Students' Intramuscular Injection Skills N/A
Not yet recruiting NCT02222779 - Quantification of Transition Metals N/A
Completed NCT01976234 - Stored RBC Transfusion and Immonomodulation N/A
Completed NCT02345135 - Susceptibility to Infections in Ataxia Telangiectasia N/A
Completed NCT01530763 - Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Community Acquired Bacterial Pneumonia (CABP) Phase 2/Phase 3
Completed NCT01158560 - A Trial of Vitamin D and Health Advice for the Prevention of Upper Respiratory Tract Infections Phase 3
Completed NCT01176786 - Reusable Versus Disposable Draping System in Breast Reconstruction Surgery N/A
Active, not recruiting NCT05284097 - Ad26.ZEBOV, MVA-BN-Filo Vaccination in Children and Adults Previously Vaccinated With Control in the EBOVAC-Salone Study Phase 2
Enrolling by invitation NCT06055712 - Antibiotic Prophylaxis in Pediatric Open Fractures Phase 4
Not yet recruiting NCT06338345 - Pharmacokinetics and Modelling of Beta-Lactam in ECMO-VA Patients N/A
Recruiting NCT06002685 - Partners in Children's Health (CSN): A Randomized Trial of an Attachment Based Intervention N/A
Completed NCT02802059 - E. Coli Nissle 1917 - Suspension for Infection Prophylaxis Phase 3
Completed NCT05289674 - The Effect of Lactoferrin in High Calorie Formula on IL-6 and IL10 in Children With Failure to Thrive and Infection N/A
Recruiting NCT05770765 - Creation of a Bank of Biological Materials and Associated Data Related to Patients With Infectious and Tropical Diseases
Completed NCT05080920 - Rosmalip® for Cancer Infections Prevention N/A
Recruiting NCT05287438 - Next Generation Sequencing Versus Traditional Cultures for Clinically Infected Penile Implants: Impact of Culture Identification on Outcomes N/A
Recruiting NCT06178822 - Towards Novel BIOmarkers to Diagnose SEPsis on the Emergency Room
Recruiting NCT05610098 - Gene Expression Profiles in Spinal Tuberculosis.

External Links